Potential vaccine treats and prevents deadly streptococcal toxic shock

Griffith Enterprise
Published
A new vaccine developed by Griffith University Institute for Glycomics researchers has the potential to treat and prevent toxic shock caused by invasive streptococcal disease, which kills more than 160,000 people every year. “Streptococcal toxic shock syndrome is an acute condition like meningococcus – if you get exposed to the organism you can be dead […]

Research provides new hope for treatment of Hand, Foot and Mouth Disease

Institute for Glycomics
Published
A new scientific discovery, thanks to one of the research groups at Griffith University’s Institute for Glycomics, is providing new hope for the development of an effective treatment of Hand, Foot and Mouth Disease (HFMD). Led by the Institute’s Founder and Director, Professor Mark von Itzstein AO, the research group has just published a paper […]

Institute for Glycomics receives US grant for vital cholera research

Institute for Glycomics
Published
Griffith’s Institute for Glycomics will share in a significant US funded grant awarded by the National Institute for Health (NIH) for a two-year research project investigating the role of Vibrio cholerae (V. cholerae) in causing widespread cholera epidemics. V. cholerae is a Gram-negative, comma-shaped bacterium/pathogen. The bacterium’s natural habitat is brackish or saltwater. Some strains of […]